JPRN-UMIN000007810已完成2 期
Phase II study of hypofractionated intensity-modulated radiation therapy using image-guided radiation techniques for prostate cancer - Phase II study of hypofractionated radiation therapy for prostate cancer
Ministry of Health, Labour and Welfare scientific research Kagami squad0 个研究点目标入组 130 人开始时间: 2012年7月2日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 130
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 50years-old 至 80years-old(—)
- 性别
- Male
入选标准
- 未提供
排除标准
- •1) Cancer patients with a duplication of activity 2) Patients with severe or uncontrollable diabetes 3) Serious medical complications (uncontrollable pulmonary disease, heart disease, kidney disease, liver disease) 4) Mental diseases which prevent from registration of this trial 5) History of pelvic radiation therapy 6) History of abdominal or pelvic surgery 7) History of prostate surgery including HIFU 8) History of chemotherapy for prostate cancer 9) Patients with inflammatory bowel disease 10) Patients treated with anticoagulant 11) IPSS >= 20 12) Risk organs are too close to the PTV to keep dose constraints. 13) Patients with metal artifacts in pelvic CT images.
研究者
相似试验
已完成
不适用
Phase II trial of hypofractionated intensity modulated radiotherapy in patients with low risk prostate cancerProstate cancerJPRN-UMIN000022570Kitasato university55
进行中(未招募)
2 期
Assessment of treatment outcome of Hypofractionated Radiotherapy using modern age radiotherapy technique with concurrent chemotherapy in Locally advanced cancers of Larynx and HypopharynxCTRI/2021/04/032672Chittaranjan National Cancer Institute
招募中
2 期
Moderately Hypofractionated Chemoradiation and Immunotherapy for Unresectable Locally Advanced Non-Small Cell Lung Cancer (MODERN-LUNG)lung cancerACTRN12620001198910Calvary Mater Newcastle50
已完成
2 期
SHORT Course Radiotherapy for Localized Prostate CancerCTRI/2016/02/006671Tata Medical Center30
进行中(未招募)
Unknown
IMAT-NeuroblastomaSpecialty: Cancer, Primary sub-specialty: Children's Cancer and LeukaemiaUKCRC code/ Disease: Cancer/ Malignant neoplasms of ill-defined, secondary and unspecified sitesNeuroblastomaCancerISRCTN10746820niversity of Birmingham50
